Monday, October 3, 2016
Breakthrough lung cancer drug made available on NHS
… suitable for patients with non-small-cell lung cancer who have a specific mutation … of EGFR T790M mutation-positive non-small-cell lung cancer, and very welcome news for … executive of the Roy Castle Lung Cancer Foundation, said: "Osimertinib represents …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment